A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Public ClinicalTrials.gov record NCT00451958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Participants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study. The study continued until all non-discontinued participants had received treatment for at least 5 years.
Study identification
- NCT ID
- NCT00451958
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 386 participants
Conditions and interventions
Conditions
Interventions
- Degarelix 80 mg / Degarelix 80 mg Drug
- Degarelix 160 mg / Degarelix 160 mg Drug
- Leuprolide 7.5 mg / Degarelix 80 mg Drug
- Leuprolide 7.5 mg / Degarelix 160 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Sep 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Mar 20, 2013
2007 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers Of Alabama | Homewood | Alabama | — | — |
| South Orange County Medical Research Center | Laguna Hills | California | — | — |
| Western Clinical Research | Torrance | California | — | — |
| Urology Associates Research | Englewood | Colorado | — | — |
| South Florida Medical Research | Aventura | Florida | — | — |
| Investigational Site | Ocala | Florida | — | — |
| Regional Urology | Shreveport | Louisiana | — | — |
| Lawrenceville Urology | Lawrenceville | New Jersey | — | — |
| Investigational Site | Carmel | New York | — | — |
| North Urology Research | Concord | North Carolina | — | — |
| Investigational Site | Greensboro | North Carolina | — | — |
| State College Urologic Association | State College | Pennsylvania | — | — |
| Urology San Antonio Research | San Antonio | Texas | — | — |
| Seattle Urology Research Center | Burien | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00451958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2013 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00451958 live on ClinicalTrials.gov.